Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Drug Resistance

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 419 articles:
HTML format
Text format



Single Articles


    July 2018
  1. WILSON RE, Hill RLR, Chalker VJ, Mentasti M, et al
    Antibiotic susceptibility of Legionella pneumophila strains isolated in England and Wales 2007-17.
    J Antimicrob Chemother. 2018 Jul 24. pii: 5057980. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. MEYGRET A, Le Roy C, Renaudin H, Bebear C, et al
    Tetracycline and fluoroquinolone resistance in clinical Ureaplasma spp. and Mycoplasma hominis isolates in France between 2010 and 2015.
    J Antimicrob Chemother. 2018 Jul 6. pii: 5050099. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. VELOO ACM, Chlebowicz M, Winter HLJ, Bathoorn D, et al
    Three metronidazole-resistant Prevotella bivia strains harbour a mobile element, encoding a novel nim gene, nimK, and an efflux small MDR transporter.
    J Antimicrob Chemother. 2018 Jul 2. pii: 5047838. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  4. BARBER KE, Pogue JM, Warnock HD, Bonomo RA, et al
    Ceftazidime/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic/pharmacodynamic model.
    J Antimicrob Chemother. 2018 Jun 22. pii: 5043126. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. TORUMKUNEY D, Nica M, Nistor I, Vatcheva-Dobrevska R, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Bulgaria, Romania, Serbia and Croatia.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036449. doi: 10.1093.
    PubMed     Text format    


  6. TORUMKUNEY D, Pertseva T, Bratus E, Dziublik A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.
    J Antimicrob Chemother. 2018 Jun 12. pii: 5036451. doi: 10.1093.
    PubMed     Text format    


  7. ZONG Z, Fenn S, Connor C, Feng Y, et al
    Complete genomic characterization of two Escherichia coli lineages responsible for a cluster of carbapenem-resistant infections in a Chinese hospital.
    J Antimicrob Chemother. 2018 Jun 11. pii: 5035906. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. FARKAS A, Sassine J, Mathew JP, Stavropoulos C, et al
    Outcomes associated with the use of a revised risk assessment strategy to predict antibiotic resistance in community-onset pneumonia: a stewardship perspective.
    J Antimicrob Chemother. 2018 Jun 11. pii: 5035907. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  9. LIN JN, Lai CH, Yang CH, Huang YH, et al
    Clinical manifestations, molecular characteristics, antimicrobial susceptibility patterns and contributions of target gene mutation to fluoroquinolone resistance in Elizabethkingia anophelis.
    J Antimicrob Chemother. 2018 May 28. pii: 5017392. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. BACHIR M, Allem R, Benejat L, Tifrit A, et al
    Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria.
    J Antimicrob Chemother. 2018 May 11. pii: 4995220. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. NYGAARD JENSEN J, Melander E, Hedin K, Bjerrum L, et al
    Comparison of antibiotic prescribing and antimicrobial resistance in urinary tract infections at the municipal level among women in two Nordic regions.
    J Antimicrob Chemother. 2018 May 10. pii: 4995081. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  12. GUPTA P, Mankere B, Chekkoora Keloth S, Tuteja U, et al
    Increased antibiotic resistance exhibited by the biofilm of Vibrio cholerae O139.
    J Antimicrob Chemother. 2018 Apr 24. pii: 4984488. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. SIMNER PJ, Antar AAR, Hao S, Gurtowski J, et al
    Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2018 Apr 10. pii: 4966148. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. NAGU TJ, Aboud S, Matee MI, Maeurer MJ, et al
    Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study-authors' response.
    J Antimicrob Chemother. 2018 Apr 4. pii: 4960907. doi: 10.1093.
    PubMed     Text format    


  15. ANTONELLI A, D'Andrea MM, Brenciani A, Galeotti CL, et al
    Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin.
    J Antimicrob Chemother. 2018 Apr 4. pii: 4960904. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. TORUMKUNEY D, Pertseva T, Bratus E, Dziublik A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  17. TORUMKUNEY D, Papaparaskevas J, Morrissey I
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Greece.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  18. TORUMKUNEY D, Zemlickova H, Maruscak M, Morrissey I, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in the Czech Republic.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  19. TORUMKUNEY D, Nica M, Nistor I, Vatcheva-Dobrevska R, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Bulgaria, Romania, Serbia and Croatia.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


  20. TORUMKUNEY D, Mayanskiy N, Edelstein M, Sidorenko S, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia.
    J Antimicrob Chemother. 2018;73.
    PubMed     Text format     Abstract available


    March 2018
  21. SCHNEIDER S, Salm F, Vincze S, Moeser A, et al
    Perceptions and attitudes regarding antibiotic resistance in Germany: a cross-sectoral survey amongst physicians, veterinarians, farmers and the general public.
    J Antimicrob Chemother. 2018 Mar 26. pii: 4953726. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. WAREHAM DW, Phee LM, Abdul Momin MHF
    Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devices.
    J Antimicrob Chemother. 2018 Mar 22. pii: 4951547. doi: 10.1093.
    PubMed     Text format    


  23. VAN HAL SJ, Beukers AG, Timms VJ, Ellem JA, et al
    Relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigation.
    J Antimicrob Chemother. 2018 Mar 16. pii: 4939528. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. PRICE L, Gozdzielewska L, Young M, Smith F, et al
    Effectiveness of interventions to improve the public's antimicrobial resistance awareness and behaviours associated with prudent use of antimicrobials: a systematic review.
    J Antimicrob Chemother. 2018 Mar 14. pii: 4937884. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. ASHLEY EA, Recht J, Chua A, Dance D, et al
    An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000.
    J Antimicrob Chemother. 2018 Mar 5. pii: 4921008. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  26. ROHDE AM, Wiese-Posselt M, Zweigner J, Schwab F, et al
    High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals.
    J Antimicrob Chemother. 2018 Feb 27. pii: 4911557. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. HEMARAJATA P, Amick T, Yang S, Gregson A, et al
    Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy.
    J Antimicrob Chemother. 2018 Feb 19. pii: 4877955. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. LEBRETON F, Valentino MD, Schaufler K, Earl AM, et al
    Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.
    J Antimicrob Chemother. 2018 Feb 14. pii: 4859672. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. DAMIAO GOUVEIA AC, Unemo M, Jensen JS
    In vitro activity of zoliflodacin (ETX0914) against macrolide-resistant, fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains.
    J Antimicrob Chemother. 2018 Feb 12. pii: 4850948. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  30. POUWELS KB, Freeman R, Muller-Pebody B, Rooney G, et al
    Association between use of different antibiotics and trimethoprim resistance: going beyond the obvious crude association.
    J Antimicrob Chemother. 2018 Jan 31. pii: 4832009. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. BRYCE A, Costelloe C, Wootton M, Butler CC, et al
    Comparison of risk factors for, and prevalence of, antibiotic resistance in contaminating and pathogenic urinary Escherichia coli in children in primary care: prospective cohort study.
    J Antimicrob Chemother. 2018 Jan 29. pii: 4828185. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. PARTRIDGE SR, Tsafnat G
    Automated annotation of mobile antibiotic resistance in Gram-negative bacteria: the Multiple Antibiotic Resistance Annotator (MARA) and database.
    J Antimicrob Chemother. 2018 Jan 23. pii: 4823430. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. XIE M, Li R, Liu Z, Chan EWC, et al
    Recombination of plasmids in a carbapenem-resistant NDM-5-producing clinical Escherichia coli isolate.
    J Antimicrob Chemother. 2018 Jan 23. pii: 4823432. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. ROZWANDOWICZ M, Brouwer MSM, Fischer J, Wagenaar JA, et al
    Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae.
    J Antimicrob Chemother. 2018 Jan 23. pii: 4822282. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. TEBANO G, la Martire G, Sarmento N, Francis JR, et al
    Antibiotic resistance in Timor-Leste: a systematic review of evidence.
    J Antimicrob Chemother. 2018 Jan 22. pii: 4819241. doi: 10.1093.
    PubMed     Text format    


  36. BASUINO L, Jousselin A, Alexander JAN, Strynadka NCJ, et al
    PBP4 activity and its overexpression are necessary for PBP4-mediated high-level beta-lactam resistance.
    J Antimicrob Chemother. 2018 Jan 19. pii: 4817624. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. HAENSSGEN MJ, Charoenboon N, Khine Zaw Y
    It is time to give social research a voice to tackle antimicrobial resistance?
    J Antimicrob Chemother. 2018 Jan 18. pii: 4817296. doi: 10.1093.
    PubMed     Text format    


  38. SASSI M, Guerin F, Lesec L, Isnard C, et al
    Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate.
    J Antimicrob Chemother. 2018 Jan 16. pii: 4812002. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. REISSIER S, Saleh-Mghir A, Guerin F, Massias L, et al
    In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
    J Antimicrob Chemother. 2018 Jan 9. pii: 4796903. doi: 10.1093.
    PubMed     Text format     Abstract available


  40. CESARO S, Dalianis T, Hanssen Rinaldo C, Koskenvuo M, et al
    ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients.
    J Antimicrob Chemother. 2018;73:12-21.
    PubMed     Text format     Abstract available


  41. ZHOU K, Yu W, Cao X, Shen P, et al
    Characterization of the population structure, drug resistance mechanisms and plasmids of the community-associated Enterobacter cloacae complex in China.
    J Antimicrob Chemother. 2018;73:66-76.
    PubMed     Text format     Abstract available


  42. CASTAGNA A, Ferrara M, Galli L, Comi L, et al
    Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus.
    J Antimicrob Chemother. 2018;73:177-182.
    PubMed     Text format     Abstract available


  43. PERRIER M, Visseaux B, Landman R, Joly V, et al
    No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir.
    J Antimicrob Chemother. 2018;73:173-176.
    PubMed     Text format     Abstract available


  44. KENGKLA K, Kongpakwattana K, Saokaew S, Apisarnthanarak A, et al
    Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis.
    J Antimicrob Chemother. 2018;73:22-32.
    PubMed     Text format     Abstract available


  45. HEIDARY M, Khosravi AD, Khoshnood S, Nasiri MJ, et al
    Daptomycin.
    J Antimicrob Chemother. 2018;73:1-11.
    PubMed     Text format     Abstract available


  46. LIVERMORE DM, Mushtaq S, Warner M, Turner SJ, et al
    Potential of high-dose cefepime/tazobactam against multiresistant Gram-negative pathogens.
    J Antimicrob Chemother. 2018;73:126-133.
    PubMed     Text format     Abstract available


  47. MALCOLM W, Fletcher E, Kavanagh K, Deshpande A, et al
    Risk factors for resistance and MDR in community urine isolates: population-level analysis using the NHS Scotland Infection Intelligence Platform.
    J Antimicrob Chemother. 2018;73:223-230.
    PubMed     Text format     Abstract available


  48. JIN L, Wang R, Wang X, Wang Q, et al
    Emergence of mcr-1 and carbapenemase genes in hospital sewage water in Beijing, China.
    J Antimicrob Chemother. 2018;73:84-87.
    PubMed     Text format     Abstract available


  49. THAKUR SD, Levett PN, Horsman GB, Dillon JR, et al
    High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003-15): time to consider point-of-care or molecular testing for precision treatment?
    J Antimicrob Chemother. 2018;73:118-125.
    PubMed     Text format     Abstract available


  50. LI Y, Li Y, Fernandez Crespo R, Leanse LG, et al
    Characterization of the Actinobacillus pleuropneumoniae SXT-related integrative and conjugative element ICEApl2 and analysis of the encoded FloR protein: hydrophobic residues in transmembrane domains contribute dynamically to florfenicol and chloramph
    J Antimicrob Chemother. 2018;73:57-65.
    PubMed     Text format     Abstract available


  51. LAI MT, Tawa P, Auger A, Wang D, et al
    Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors.
    J Antimicrob Chemother. 2018;73:109-117.
    PubMed     Text format     Abstract available


  52. BOTELHO J, Grosso F, Peixe L
    Unravelling the genome of a Pseudomonas aeruginosa isolate belonging to the high-risk clone ST235 reveals an integrative conjugative element housing a blaGES-6 carbapenemase.
    J Antimicrob Chemother. 2018;73:77-83.
    PubMed     Text format     Abstract available


    December 2017
  53. VAN DEN BUNT G, Top J, Hordijk J, de Greeff SC, et al
    Intestinal carriage of ampicillin- and vancomycin-resistant Enterococcus faecium in humans, dogs and cats in the Netherlands.
    J Antimicrob Chemother. 2017 Dec 25. pii: 4774625. doi: 10.1093.
    PubMed     Text format     Abstract available


  54. DECROO T, Van Deun A, Lynen L
    Comment on: Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study.
    J Antimicrob Chemother. 2017 Dec 25. pii: 4774628. doi: 10.1093.
    PubMed     Text format    


  55. KLOTZ P, Jacobmeyer L, Stamm I, Leidner U, et al
    Carbapenem-resistant Acinetobacter baumannii ST294 harbouring the OXA-72 carbapenemase from a captive grey parrot.
    J Antimicrob Chemother. 2017 Dec 21. pii: 4772354. doi: 10.1093.
    PubMed     Text format    


  56. BERGLUND B, Hoang NTB, Tarnberg M, Le NK, et al
    Colistin- and carbapenem-resistant Klebsiella pneumoniae carrying mcr-1 and blaOXA-48 isolated at a paediatric hospital in Vietnam.
    J Antimicrob Chemother. 2017 Dec 15. pii: 4748887. doi: 10.1093.
    PubMed     Text format    


  57. WOODFORD N, Xu-McCrae L, Mushtaq S, Wu HHT, et al
    Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK).
    J Antimicrob Chemother. 2017 Dec 15. pii: 4748884. doi: 10.1093.
    PubMed     Text format     Abstract available


  58. CASPAR Y, Hennebique A, Maurin M
    Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
    J Antimicrob Chemother. 2017 Dec 14. pii: 4745834. doi: 10.1093.
    PubMed     Text format     Abstract available


  59. HARRIS PNA, Ben Zakour NL, Roberts LW, Wailan AM, et al
    Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
    J Antimicrob Chemother. 2017 Dec 14. pii: 4745835. doi: 10.1093.
    PubMed     Text format     Abstract available


  60. DAY MR, Doumith M, Do Nascimento V, Nair S, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi.
    J Antimicrob Chemother. 2017 Dec 5. pii: 4693726. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  61. HOMBACH M, Jetter M, Blochliger N, Kolesnik-Goldmann N, et al
    Rapid disc diffusion antibiotic susceptibility testing for Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus spp.
    J Antimicrob Chemother. 2017 Nov 23. pii: 4654829. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. FJALSTAD JW, Esaiassen E, Juvet LK, van den Anker JN, et al
    Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review.
    J Antimicrob Chemother. 2017 Nov 22. pii: 4652876. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. LEE RS, Seemann T, Heffernan H, Kwong JC, et al
    Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand.
    J Antimicrob Chemother. 2017 Nov 22. pii: 4647718. doi: 10.1093.
    PubMed     Text format     Abstract available


  64. CAI Y, Yang D, Wang J, Wang R, et al
    Activity of colistin alone or in combination with rifampicin or meropenem in a carbapenem-resistant bioluminescent Pseudomonas aeruginosa intraperitoneal murine infection model.
    J Antimicrob Chemother. 2017 Nov 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  65. MARQUES C, Belas A, Franco A, Aboim C, et al
    Increase in antimicrobial resistance and emergence of major international high-risk clonal lineages in dogs and cats with urinary tract infection: 16 year retrospective study.
    J Antimicrob Chemother. 2017 Nov 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  66. KOSHKOLDA T, Luck C
    Antibiotic susceptibility of clinical Legionella pneumophila serogroup 1 strains isolated in Germany.
    J Antimicrob Chemother. 2017 Nov 9. doi: 10.1093.
    PubMed     Text format    


    October 2017
  67. DORTET L, Glaser P, Kassis-Chikhani N, Girlich D, et al
    Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France.
    J Antimicrob Chemother. 2017 Oct 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  68. CHEN CJ, Lauderdale TY, Lu CT, Chuang YY, et al
    Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. BUIL JB, Bruggemann RJM, Wasmann RE, Zoll J, et al
    Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
    J Antimicrob Chemother. 2017 Oct 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  70. HOLYK A, Belden V, Lee JJ, Musick W, et al
    Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format    


  71. BREAK TJ, Desai JV, Natarajan M, Ferre EMN, et al
    VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
    J Antimicrob Chemother. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  72. JIMENEZ-CASTELLANOS JC, Wan Nur Ismah WAK, Takebayashi Y, Findlay J, et al
    Envelope proteome changes driven by RamA overproduction in Klebsiella pneumoniae that enhance acquired beta-lactam resistance.
    J Antimicrob Chemother. 2017 Oct 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. MCDONNELL L, Armstrong D, Ashworth M, Dregan A, et al
    National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries-authors' response.
    J Antimicrob Chemother. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format    


  74. ARENDRUP MC, Verweij PE, Mouton JW, Lagrou K, et al
    Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  75. ZHANG Y, Kashikar A, Bush K
    In vitro activity of plazomicin against beta-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
    J Antimicrob Chemother. 2017;72:2792-2795.
    PubMed     Text format     Abstract available


  76. BRENNAN-KROHN T, Truelson KA, Smith KP, Kirby JE, et al
    Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.
    J Antimicrob Chemother. 2017;72:2775-2781.
    PubMed     Text format     Abstract available


  77. ZANKARI E, Allesoe R, Joensen KG, Cavaco LM, et al
    PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens.
    J Antimicrob Chemother. 2017;72:2764-2768.
    PubMed     Text format     Abstract available


  78. OVIANO M, Gomara M, Barba MJ, Sparbier K, et al
    Quantitative and automated MALDI-TOF MS-based detection of the plasmid-mediated quinolone resistance determinant AAC(6')-Ib-cr in Enterobacteriaceae.
    J Antimicrob Chemother. 2017;72:2952-2954.
    PubMed     Text format    


  79. LEE MC, Sun PL, Wu TL, Wang LH, et al
    Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
    J Antimicrob Chemother. 2017;72:2782-2786.
    PubMed     Text format     Abstract available


  80. DOUMITH M, Mushtaq S, Martin V, Chaudhry A, et al
    Genomic sequences of Streptococcus agalactiae with high-level gentamicin resistance, collected in the BSAC bacteraemia surveillance.
    J Antimicrob Chemother. 2017;72:2704-2707.
    PubMed     Text format     Abstract available


  81. WEBBER MA, Buckner MMC, Redgrave LS, Ifill G, et al
    Quinolone-resistant gyrase mutants demonstrate decreased susceptibility to triclosan.
    J Antimicrob Chemother. 2017;72:2755-2763.
    PubMed     Text format     Abstract available


  82. SCORNEC H, Bellanger X, Guilloteau H, Groshenry G, et al
    Inducibility of Tn916 conjugative transfer in Enterococcus faecalis by subinhibitory concentrations of ribosome-targeting antibiotics.
    J Antimicrob Chemother. 2017;72:2722-2728.
    PubMed     Text format     Abstract available


    September 2017
  83. ARANA DM, Ortega A, Gonzalez-Barbera E, Lara N, et al
    Carbapenem-resistant Citrobacter spp. isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2.
    J Antimicrob Chemother. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. ZHANG Q, Hua X, Ruan Z, Yu Y, et al
    Revisiting the contribution of gene duplication of blaOXA-23 in carbapenem-resistant Acinetobacter baumannii.
    J Antimicrob Chemother. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format    


  85. FREITAS AR, Elghaieb H, Leon-Sampedro R, Abbassi MS, et al
    Detection of optrA in the African continent (Tunisia) within a mosaic Enterococcus faecalis plasmid from urban wastewaters.
    J Antimicrob Chemother. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  86. PULCINI C
    Comment on: National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries.
    J Antimicrob Chemother. 2017 Sep 18. doi: 10.1093.
    PubMed     Text format    


  87. CHEN J, Zhang S, Cui P, Shi W, et al
    Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017 Sep 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  88. DO NASCIMENTO V, Day MR, Doumith M, Hopkins KL, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of enteroaggregative Escherichia coli isolated from cases of diarrhoeal disease in England, 2015-16.
    J Antimicrob Chemother. 2017 Sep 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  89. WU CJ, Lai JF, Huang IW, Hsieh LY, et al
    Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan.
    J Antimicrob Chemother. 2017 Sep 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  90. SRIVASTAVA S, Deshpande D, Gumbo T
    Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  91. LEE GC, Dallas SD, Wang Y, Olsen RJ, et al
    Emerging multidrug resistance in community-associated Staphylococcus aureus involved in skin and soft tissue infections and nasal colonization.
    J Antimicrob Chemother. 2017;72:2461-2468.
    PubMed     Text format     Abstract available


    August 2017
  92. LAZARIS A, Coleman DC, Kearns AM, Pichon B, et al
    Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE.
    J Antimicrob Chemother. 2017 Aug 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  93. CHANG SC, Lee MH, Yeh CF, Liu TP, et al
    Characterization of two novel variants of staphylococcal cassette chromosome mec elements in oxacillin-resistant Staphylococcus lugdunensis.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  94. ATKINSON CT, Kunde DA, Tristram SG
    Expression of acquired macrolide resistance genes in Haemophilus influenzae.
    J Antimicrob Chemother. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  95. PRASKI ALZRIGAT L, Huseby DL, Brandis G, Hughes D, et al
    Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli.
    J Antimicrob Chemother. 2017 Aug 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  96. NIGRO SJ, Hall RM
    A large plasmid, pD46-4, carrying a complex resistance region in an extensively antibiotic-resistant ST25 Acinetobacter baumannii.
    J Antimicrob Chemother. 2017 Aug 14. doi: 10.1093.
    PubMed     Text format    


  97. HOMBACH M, Jetter M, Keller PM, Blochliger N, et al
    Rapid detection of ESBL, carbapenemases, MRSA and other important resistance phenotypes within 6-8 h by automated disc diffusion antibiotic susceptibility testing.
    J Antimicrob Chemother. 2017 Aug 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  98. SCHAUWVLIEGHE AFAD, Vonk AG, Buddingh EP, Hoek RAS, et al
    Detection of azole-susceptible and azole-resistant Aspergillus coinfection by cyp51A PCR amplicon melting curve analysis.
    J Antimicrob Chemother. 2017 Aug 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  99. ZELLWEGER RM, Carrique-Mas J, Limmathurotsakul D, Day NPJ, et al
    A current perspective on antimicrobial resistance in Southeast Asia.
    J Antimicrob Chemother. 2017 Aug 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  100. WEBER RE, Layer F, Klare I, Werner G, et al
    Comparative evaluation of VITEK(R) 2 and three commercial gradient strip assays for daptomycin susceptibility testing of Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Aug 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  101. SMITH NM, Bulman ZP, Sieron AO, Bulitta JB, et al
    Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli.
    J Antimicrob Chemother. 2017;72:2297-2303.
    PubMed     Text format     Abstract available


  102. ROMINSKI A, Selchow P, Becker K, Brulle JK, et al
    Elucidation of Mycobacterium abscessus aminoglycoside and capreomycin resistance by targeted deletion of three putative resistance genes.
    J Antimicrob Chemother. 2017;72:2191-2200.
    PubMed     Text format     Abstract available


  103. BRENNER BG, Ibanescu RI, Oliveira M, Roger M, et al
    HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters.
    J Antimicrob Chemother. 2017;72:2171-2183.
    PubMed     Text format     Abstract available


  104. SOULIE C, Grude M, Descamps D, Amiel C, et al
    Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
    J Antimicrob Chemother. 2017;72:2351-2354.
    PubMed     Text format     Abstract available


  105. OVIANO M, Gomara M, Barba MJ, Revillo MJ, et al
    Towards the early detection of beta-lactamase-producing Enterobacteriaceae by MALDI-TOF MS analysis.
    J Antimicrob Chemother. 2017;72:2259-2262.
    PubMed     Text format     Abstract available


    July 2017
  106. FIRSOV AA, Alieva KN, Strukova EN, Golikova MV, et al
    Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.
    J Antimicrob Chemother. 2017 Jul 31. doi: 10.1093.
    PubMed     Text format     Abstract available


  107. MCDONNELL L, Armstrong D, Ashworth M, Dregan A, et al
    National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries.
    J Antimicrob Chemother. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  108. KWON HI, Kim S, Oh MH, Na SH, et al
    Outer membrane protein A contributes to antimicrobial resistance of Acinetobacter baumannii through the OmpA-like domain.
    J Antimicrob Chemother. 2017 Jul 24. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2017
  109. HAMIDIAN M, Hall RM
    Origin of the AbGRI1 antibiotic resistance island found in the comM gene of Acinetobacter baumannii GC2 isolates.
    J Antimicrob Chemother. 2017 Jun 28. doi: 10.1093.
    PubMed     Text format    


  110. DI SANTE L, Morroni G, Brenciani A, Vignaroli C, et al
    pHTbeta-promoted mobilization of non-conjugative resistance plasmids from Enterococcus faecium to Enterococcus faecalis.
    J Antimicrob Chemother. 2017 Jun 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  111. VOURLI S, Dafopoulou K, Vrioni G, Tsakris A, et al
    Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates.
    J Antimicrob Chemother. 2017 Jun 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  112. TOMASO H, Hotzel H, Otto P, Myrtennas K, et al
    Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
    J Antimicrob Chemother. 2017 Jun 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  113. BUIL JB, Rijs AJMM, Meis JF, Birch M, et al
    In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
    J Antimicrob Chemother. 2017 Jun 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  114. POWELL N, Davidson I, Yelling P, Collinson A, et al
    Developing a local antimicrobial resistance action plan: the Cornwall One Health Antimicrobial Resistance Group.
    J Antimicrob Chemother. 2017 Jun 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  115. SADOUKI Z, Day MR, Doumith M, Chattaway MA, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Shigella sonnei isolated from cases of diarrhoeal disease in England and Wales, 2015.
    J Antimicrob Chemother. 2017 Jun 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  116. STANCZAK-MROZEK KI, Laing KG, Lindsay JA
    Resistance gene transfer: induction of transducing phage by sub-inhibitory concentrations of antimicrobials is not correlated to induction of lytic phage.
    J Antimicrob Chemother. 2017;72:1624-1631.
    PubMed     Text format     Abstract available


  117. MUSICHA P, Feasey NA, Cain AK, Kallonen T, et al
    Genomic landscape of extended-spectrum beta-lactamase resistance in Escherichia coli from an urban African setting.
    J Antimicrob Chemother. 2017;72:1602-1609.
    PubMed     Text format     Abstract available


  118. MUSHTAQ S, Vickers A, Woodford N, Livermore DM, et al
    WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D beta-lactamases.
    J Antimicrob Chemother. 2017;72:1688-1695.
    PubMed     Text format     Abstract available


  119. ANDRADE SD, Sabido M, Monteiro WM, Benzaken AS, et al
    Drug resistance in antiretroviral-naive children newly diagnosed with HIV-1 in Manaus, Amazonas.
    J Antimicrob Chemother. 2017;72:1774-1783.
    PubMed     Text format     Abstract available


  120. HOBBS MR, Grant CC, Ritchie SR, Chelimo C, et al
    Antibiotic consumption by New Zealand children: exposure is near universal by the age of 5 years.
    J Antimicrob Chemother. 2017;72:1832-1840.
    PubMed     Text format     Abstract available


  121. BRETAGNE S, Renaudat C, Desnos-Ollivier M, Sitbon K, et al
    Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14).
    J Antimicrob Chemother. 2017;72:1784-1793.
    PubMed     Text format     Abstract available


  122. ASSOUMOU L, Charpentier C, Recordon-Pinson P, Grude M, et al
    Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.
    J Antimicrob Chemother. 2017;72:1769-1773.
    PubMed     Text format     Abstract available


  123. ZHOU YF, Tao MT, Feng Y, Yang RS, et al
    Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1.
    J Antimicrob Chemother. 2017;72:1723-1730.
    PubMed     Text format     Abstract available


  124. NISHIKAWA H, Fukuda Y, Mitsuyama J, Tashiro M, et al
    In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
    J Antimicrob Chemother. 2017;72:1709-1713.
    PubMed     Text format     Abstract available


  125. TANG Y, Dai L, Sahin O, Wu Z, et al
    Emergence of a plasmid-borne multidrug resistance gene cfr(C) in foodborne pathogen Campylobacter.
    J Antimicrob Chemother. 2017;72:1581-1588.
    PubMed     Text format     Abstract available


  126. KAUSHIK A, Ammerman NC, Tasneen R, Story-Roller E, et al
    In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2017 Jun 1. doi: 10.1093.
    PubMed     Text format     Abstract available


  127. HURST SF, Berkow EL, Stevenson KL, Litvintseva AP, et al
    Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA.
    J Antimicrob Chemother. 2017 Jun 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  128. ALAUZET C, Berger S, Jean-Pierre H, Dubreuil L, et al
    nimH, a novel nitroimidazole resistance gene contributing to metronidazole resistance in Bacteroides fragilis.
    J Antimicrob Chemother. 2017 May 23. doi: 10.1093.
    PubMed     Text format    


  129. SHU JC, Kuo AJ, Su LH, Liu TP, et al
    Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170.
    J Antimicrob Chemother. 2017 May 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  130. AMBROSIONI J, Mosquera MM, Miro JM
    Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection-authors' response.
    J Antimicrob Chemother. 2017;72:1547-1548.
    PubMed     Text format    


  131. FABRIZIO C, Lepore L, Lagioia A, Punzi G, et al
    Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection.
    J Antimicrob Chemother. 2017;72:1546-1547.
    PubMed     Text format    


  132. PFALLER MA, Bassetti M, Duncan LR, Castanheira M, et al
    Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15).
    J Antimicrob Chemother. 2017;72:1386-1395.
    PubMed     Text format     Abstract available


  133. GOODALL RL, Dunn DT, Nkurunziza P, Mugarura L, et al
    Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa.
    J Antimicrob Chemother. 2017;72:1450-1455.
    PubMed     Text format     Abstract available


  134. TAM VH, Chang KT, Zhou J, Ledesma KR, et al
    Determining beta-lactam exposure threshold to suppress resistance development in Gram-negative bacteria.
    J Antimicrob Chemother. 2017;72:1421-1428.
    PubMed     Text format     Abstract available


  135. GUENTHER S, Falgenhauer L, Semmler T, Imirzalioglu C, et al
    Environmental emission of multiresistant Escherichia coli carrying the colistin resistance gene mcr-1 from German swine farms.
    J Antimicrob Chemother. 2017;72:1289-1292.
    PubMed     Text format     Abstract available


  136. DUPRILOT M, Decre D, Genel N, Drieux L, et al
    Diversity and functionality of plasmid-borne VagCD toxin-antitoxin systems of Klebsiella pneumoniae.
    J Antimicrob Chemother. 2017;72:1320-1326.
    PubMed     Text format     Abstract available


  137. ROUKENS M, Verhoef L, Stobberingh E, Natsch S, et al
    Surveillance of antimicrobial use in Dutch long-term care facilities.
    J Antimicrob Chemother. 2017;72:1516-1520.
    PubMed     Text format     Abstract available


  138. BALLESTERO-TELLEZ M, Docobo-Perez F, Portillo-Calderon I, Rodriguez-Martinez JM, et al
    Molecular insights into fosfomycin resistance in Escherichia coli.
    J Antimicrob Chemother. 2017;72:1303-1309.
    PubMed     Text format     Abstract available


  139. LANGE F, Pfennigwerth N, Gerigk S, Gohlke F, et al
    Dissemination of blaOXA-58 in Proteus mirabilis isolates from Germany.
    J Antimicrob Chemother. 2017;72:1334-1339.
    PubMed     Text format     Abstract available


  140. VAN EIJK E, Wittekoek B, Kuijper EJ, Smits WK, et al
    DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens.
    J Antimicrob Chemother. 2017;72:1275-1284.
    PubMed     Text format     Abstract available


    April 2017
  141. EHRMANN E, Jolivet-Gougeon A, Bonnaure-Mallet M, Fosse T, et al
    Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.
    J Antimicrob Chemother. 2017 Apr 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  142. ZIMENKOV DV, Nosova EY, Kulagina EV, Antonova OV, et al
    Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region.
    J Antimicrob Chemother. 2017 Apr 6. doi: 10.1093.
    PubMed     Text format     Abstract available


  143. OVEJERO CM, Delgado-Blas JF, Calero-Caceres W, Muniesa M, et al
    Spread of mcr-1-carrying Enterobacteriaceae in sewage water from Spain.
    J Antimicrob Chemother. 2017;72:1050-1053.
    PubMed     Text format     Abstract available


  144. PFENNIGWERTH N, Lange F, Belmar Campos C, Hentschke M, et al
    Genetic and biochemical characterization of HMB-1, a novel subclass B1 metallo-beta-lactamase found in a Pseudomonas aeruginosa clinical isolate.
    J Antimicrob Chemother. 2017;72:1068-1073.
    PubMed     Text format     Abstract available


  145. CROSS EL, Tolfree R, Kipping R
    Systematic review of public-targeted communication interventions to improve antibiotic use.
    J Antimicrob Chemother. 2017;72:975-987.
    PubMed     Text format     Abstract available


  146. WATTAL C, Chakrabarti A, Oberoi JK, Donnelly JP, et al
    Issues in antifungal stewardship: an opportunity that should not be lost.
    J Antimicrob Chemother. 2017;72:969-974.
    PubMed     Text format     Abstract available


  147. JOHNSON AP, Muller-Pebody B, Budd E, Ashiru-Oredope D, et al
    Improving feedback of surveillance data on antimicrobial consumption, resistance and stewardship in England: putting the data at your Fingertips.
    J Antimicrob Chemother. 2017;72:953-956.
    PubMed     Text format     Abstract available


  148. CHAPMAN B, Slavin M, Marriott D, Halliday C, et al
    Changing epidemiology of candidaemia in Australia.
    J Antimicrob Chemother. 2017;72:1103-1108.
    PubMed     Text format     Abstract available


  149. MADELAIN V, Le MP, Champenois K, Charpentier C, et al
    Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
    J Antimicrob Chemother. 2017;72:1137-1146.
    PubMed     Text format     Abstract available


  150. SOUSA DOMINGUEZ A, Perez-Rodriguez MT, Nodar A, Martinez-Lamas L, et al
    Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam.
    J Antimicrob Chemother. 2017;72:1262-1263.
    PubMed     Text format    


    March 2017
  151. SAN-JUAN R, Fernandez-Ruiz M, Gasch O, Camoez M, et al
    High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Mar 31. doi: 10.1093.
    PubMed     Text format     Abstract available


  152. FALAGAS ME, Skalidis T, Vardakas KZ, Legakis NJ, et al
    Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
    J Antimicrob Chemother. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  153. ROER L, Hansen F, Thomsen MC, Knudsen JD, et al
    WGS-based surveillance of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
    J Antimicrob Chemother. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  154. HAMIDIAN M, Nigro SJ, Hartstein RM, Hall RM, et al
    RCH51, a multiply antibiotic-resistant Acinetobacter baumannii ST103IP isolate, carries resistance genes in three plasmids, including a novel potentially conjugative plasmid carrying oxa235 in transposon Tn6252.
    J Antimicrob Chemother. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  155. HAWKINS PA, Law CS, Metcalf BJ, Chochua S, et al
    Cross-resistance to lincosamides, streptogramins A and pleuromutilins in Streptococcus agalactiae isolates from the USA.
    J Antimicrob Chemother. 2017 Mar 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  156. JAGANATH D, Schaaf HS, Donald PR
    Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.
    J Antimicrob Chemother. 2017 Mar 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  157. GRONTHAL T, Eklund M, Thomson K, Piiparinen H, et al
    Antimicrobial resistance in Staphylococcus pseudintermedius and the molecular epidemiology of methicillin-resistant S. pseudintermedius in small animals in Finland.
    J Antimicrob Chemother. 2017 Mar 8. doi: 10.1093.
    PubMed     Text format    


  158. DE LASTOURS V, Maugy E, Mathy V, Chau F, et al
    Ecological impact of ciprofloxacin on commensal enterococci in healthy volunteers.
    J Antimicrob Chemother. 2017 Mar 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  159. LASS-FLORL C, Cuenca-Estrella M
    Changes in the epidemiological landscape of invasive mould infections and disease.
    J Antimicrob Chemother. 2017;72.
    PubMed     Text format     Abstract available


  160. STEFIC K, Salmona M, Capitao M, Splittgerber M, et al
    Unravelling the dynamics of selection of multiresistant variants to integrase inhibitors in an HIV-1-infected child using ultra-deep sequencing.
    J Antimicrob Chemother. 2017;72:850-854.
    PubMed     Text format     Abstract available


  161. SULLY EK, Geller BL, Li L, Moody CM, et al
    Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.
    J Antimicrob Chemother. 2017;72:782-790.
    PubMed     Text format     Abstract available


  162. KLETENKOV K, Hoffmann D, Boni J, Yerly S, et al
    Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?
    J Antimicrob Chemother. 2017;72:866-875.
    PubMed     Text format     Abstract available


  163. DUGGETT NA, Sayers E, AbuOun M, Ellis RJ, et al
    Occurrence and characterization of mcr-1-harbouring Escherichia coli isolated from pigs in Great Britain from 2013 to 2015.
    J Antimicrob Chemother. 2017;72:691-695.
    PubMed     Text format     Abstract available


  164. BRIAND C, Dollfus C, Faye A, Kantor E, et al
    Efficacy and tolerance of dolutegravir-based combined ART in perinatally HIV-1-infected adolescents: a French multicentre retrospective study.
    J Antimicrob Chemother. 2017;72:837-843.
    PubMed     Text format     Abstract available


    February 2017
  165. LENHARD JR, Thamlikitkul V, Silveira FP, Garonzik SM, et al
    Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    J Antimicrob Chemother. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  166. MOUGARI F, Loiseau J, Veziris N, Bernard C, et al
    Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    J Antimicrob Chemother. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  167. CAVANAUGH JS, Jou R, Wu MH, Dalton T, et al
    Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
    J Antimicrob Chemother. 2017 Feb 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  168. HOMBACH M, Jetter M, Blochliger N, Kolesnik-Goldmann N, et al
    Fully automated disc diffusion for rapid antibiotic susceptibility test results: a proof-of-principle study.
    J Antimicrob Chemother. 2017 Feb 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  169. PERICAS JM, Garcia-de-la-Maria C, Brunet M, Armero Y, et al
    Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    J Antimicrob Chemother. 2017 Feb 14. doi: 10.1093.
    PubMed     Text format    


  170. ROWE WP, Baker-Austin C, Verner-Jeffreys DW, Ryan JJ, et al
    Overexpression of antibiotic resistance genes in hospital effluents over time.
    J Antimicrob Chemother. 2017 Feb 8. doi: 10.1093.
    PubMed     Text format    


  171. WANG J, Guo ZW, Zhi CP, Yang T, et al
    Impact of plasmid-borne oqxAB on the development of fluoroquinolone resistance and bacterial fitness in Escherichia coli.
    J Antimicrob Chemother. 2017 Feb 4. doi: 10.1093.
    PubMed     Text format    


  172. BRAAM JF, Slotboom B, Van Marm S, Severs TT, et al
    High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands.
    J Antimicrob Chemother. 2017 Feb 3. doi: 10.1093.
    PubMed     Text format    


  173. BOIKOV DA, Locke JB, James KD, Bartizal K, et al
    In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
    J Antimicrob Chemother. 2017 Feb 3. doi: 10.1093.
    PubMed     Text format    


  174. MUNK P, Andersen VD, de Knegt L, Jensen MS, et al
    A sampling and metagenomic sequencing-based methodology for monitoring antimicrobial resistance in swine herds.
    J Antimicrob Chemother. 2017;72:385-392.
    PubMed     Text format     Abstract available


  175. LI R, Xie M, Zhang J, Yang Z, et al
    Genetic characterization of mcr-1-bearing plasmids to depict molecular mechanisms underlying dissemination of the colistin resistance determinant.
    J Antimicrob Chemother. 2017;72:393-401.
    PubMed     Text format     Abstract available


  176. BOERMA RS, Sigaloff KC, Akanmu AS, Inzaule S, et al
    Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2017;72:365-371.
    PubMed     Text format     Abstract available


  177. ZAHEDI BIALVAEI A, Rahbar M, Yousefi M, Asgharzadeh M, et al
    Linezolid: a promising option in the treatment of Gram-positives.
    J Antimicrob Chemother. 2017;72:354-364.
    PubMed     Text format     Abstract available


  178. ROMINSKI A, Roditscheff A, Selchow P, Bottger EC, et al
    Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591.
    J Antimicrob Chemother. 2017;72:376-384.
    PubMed     Text format     Abstract available


  179. BEYROUTHY R, Robin F, Hamze M, Bonnet R, et al
    IncFIIk plasmid harbouring an amplification of 16S rRNA methyltransferase-encoding gene rmtH associated with mobile element ISCR2.
    J Antimicrob Chemother. 2017;72:402-406.
    PubMed     Text format     Abstract available


  180. PADGET M, Tamarelle J, Herindrainy P, Ndir A, et al
    A community survey of antibiotic consumption among children in Madagascar and Senegal: the importance of healthcare access and care quality.
    J Antimicrob Chemother. 2017;72:564-573.
    PubMed     Text format     Abstract available


  181. GONZALEZ-SERNA A, Glas AC, Brumme CJ, Poon AF, et al
    Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load.
    J Antimicrob Chemother. 2017;72:496-503.
    PubMed     Text format     Abstract available


  182. TAN C, Vermeulen M, Wang X, Zvonar R, et al
    Variability in antibiotic use across Ontario acute care hospitals.
    J Antimicrob Chemother. 2017;72:554-563.
    PubMed     Text format     Abstract available


  183. BAILEY C, Tully MP, Pampaka M, Cooke J, et al
    Rasch analysis of the Antimicrobial Self-Assessment Toolkit for National Health Service (NHS) Trusts (ASAT v17).
    J Antimicrob Chemother. 2017;72:604-613.
    PubMed     Text format     Abstract available


  184. NY S, Lofmark S, Borjesson S, Englund S, et al
    Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study.
    J Antimicrob Chemother. 2017;72:582-588.
    PubMed     Text format     Abstract available


  185. BISSIO E, Barbas MG, Bouzas MB, Cudola A, et al
    Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014-15.
    J Antimicrob Chemother. 2017;72:504-510.
    PubMed     Text format     Abstract available


  186. SADAHIRA T, Wada K, Araki M, Ishii A, et al
    Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial.
    J Antimicrob Chemother. 2017;72:529-534.
    PubMed     Text format     Abstract available


  187. TREPANIER P, Mallard K, Meunier D, Pike R, et al
    Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures.
    J Antimicrob Chemother. 2017;72:596-603.
    PubMed     Text format     Abstract available


  188. CABELLO FC, Godfrey HP
    Comment on: Transferable resistance to colistin: a new but old threat.
    J Antimicrob Chemother. 2017;72:636-637.
    PubMed     Text format    


    January 2017
  189. SUGIANLI AK, Ginting F, Kusumawati RL, Pranggono EH, et al
    Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia.
    J Antimicrob Chemother. 2017 Jan 30. pii: dkw578. doi: 10.1093.
    PubMed     Text format     Abstract available


  190. MASSIP C, Descours G, Ginevra C, Doublet P, et al
    Macrolide resistance in Legionella pneumophila: the role of LpeAB efflux pump.
    J Antimicrob Chemother. 2017 Jan 30. pii: dkw594. doi: 10.1093.
    PubMed     Text format     Abstract available


  191. TSANG RS, Shuel M, Whyte K, Hoang L, et al
    Antibiotic susceptibility and molecular analysis of invasive Haemophilus influenzae in Canada, 2007 to 2014.
    J Antimicrob Chemother. 2017 Jan 30. pii: dkw565. doi: 10.1093.
    PubMed     Text format     Abstract available


  192. LEDDA A, Price JR, Cole K, Llewelyn MJ, et al
    Re-emergence of methicillin susceptibility in a resistant lineage of Staphylococcus aureus.
    J Antimicrob Chemother. 2017 Jan 20. pii: dkw570. doi: 10.1093.
    PubMed     Text format     Abstract available


  193. MISCHNIK A, Baumert P, Hamprecht A, Rohde AM, et al
    In vitro susceptibility to 19 agents other than beta-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
    J Antimicrob Chemother. 2017 Jan 19. pii: dkw577. doi: 10.1093.
    PubMed     Text format     Abstract available


  194. STONE GG, Bradford PA, Yates K, Newell P, et al
    In vitro activity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections.
    J Antimicrob Chemother. 2017 Jan 14. pii: dkw561. doi: 10.1093.
    PubMed     Text format     Abstract available


  195. MATSUMURA Y, Noguchi T, Tanaka M, Kanahashi T, et al
    Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance.
    J Antimicrob Chemother. 2017 Jan 10. pii: dkw530. doi: 10.1093.
    PubMed     Text format     Abstract available


  196. SY SK, Zhuang L, Beaudoin ME, Kircher P, et al
    Potentiation of ceftazidime by avibactam against beta-lactam-resistant Pseudomonas aeruginosa in an in vitro infection model.
    J Antimicrob Chemother. 2017 Jan 10. pii: dkw535. doi: 10.1093.
    PubMed     Text format     Abstract available


  197. ROSELLO A, Hayward AC, Hopkins S, Horner C, et al
    Impact of long-term care facility residence on the antibiotic resistance of urinary tract Escherichia coli and Klebsiella.
    J Antimicrob Chemother. 2017 Jan 10. pii: dkw555. doi: 10.1093.
    PubMed     Text format     Abstract available


  198. BLACKWELL GA, Holt KE, Bentley SD, Hsu LY, et al
    Variants of AbGRI3 carrying the armA gene in extensively antibiotic-resistant Acinetobacter baumannii from Singapore.
    J Antimicrob Chemother. 2017 Jan 10. pii: dkw542. doi: 10.1093.
    PubMed     Text format     Abstract available


  199. GRONTHAL T, Eklund M, Thomson K, Piiparinen H, et al
    Antimicrobial resistance in Staphylococcus pseudintermedius and the molecular epidemiology of methicillin-resistant S. pseudintermedius in small animals in Finland.
    J Antimicrob Chemother. 2017 Jan 8. pii: dkw559. doi: 10.1093.
    PubMed     Text format     Abstract available


  200. OVIANO M, Rodriguez-Martinez JM, Pascual A, Bou G, et al
    Rapid detection of the plasmid-mediated quinolone resistance determinant AAC(6')-Ib-cr in Enterobacteriaceae by MALDI-TOF MS analysis.
    J Antimicrob Chemother. 2017 Jan 8. pii: dkw552. doi: 10.1093.
    PubMed     Text format     Abstract available


  201. XISTO MI, Caramalho RD, Rocha DA, Ferreira-Pereira A, et al
    Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?
    J Antimicrob Chemother. 2017 Jan 8. pii: dkw558. doi: 10.1093.
    PubMed     Text format     Abstract available


  202. OTSUKA T, Brauer AL, Kirkham C, Sully EK, et al
    Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.
    J Antimicrob Chemother. 2017;72:137-144.
    PubMed     Text format     Abstract available


  203. CUNNINGHAM E, Chan YT, Aghaizu A, Bibby DF, et al
    Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK.
    J Antimicrob Chemother. 2017;72:227-234.
    PubMed     Text format     Abstract available


  204. DEGHMANE AE, Hong E, Taha MK
    Emergence of meningococci with reduced susceptibility to third-generation cephalosporins.
    J Antimicrob Chemother. 2017;72:95-98.
    PubMed     Text format     Abstract available


  205. STEEGEN K, Bronze M, Papathanasopoulos MA, van Zyl G, et al
    HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa.
    J Antimicrob Chemother. 2017;72:210-219.
    PubMed     Text format     Abstract available


  206. SHARMA A, Sharma R, Bhattacharyya T, Bhando T, et al
    Fosfomycin resistance in Acinetobacter baumannii is mediated by efflux through a major facilitator superfamily (MFS) transporter-AbaF.
    J Antimicrob Chemother. 2017;72:68-74.
    PubMed     Text format     Abstract available


  207. AMBROSIONI J, Nicolas D, Manzardo C, Aguero F, et al
    Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection.
    J Antimicrob Chemother. 2017;72:205-209.
    PubMed     Text format     Abstract available


    December 2016
  208. MORAN RA, Anantham S, Holt KE, Hall RM, et al
    Prediction of antibiotic resistance from antibiotic resistance genes detected in antibiotic-resistant commensal Escherichia coli using PCR or WGS.
    J Antimicrob Chemother. 2016 Dec 30. pii: dkw511. doi: 10.1093.
    PubMed     Text format     Abstract available


  209. RANDALL LB, Georgi E, Genzel GH, Schweizer HP, et al
    Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance.
    J Antimicrob Chemother. 2016 Dec 30. pii: dkw529. doi: 10.1093.
    PubMed     Text format    


  210. ZHU XQ, Wang XM, Li H, Shang YH, et al
    Novel lnu(G) gene conferring resistance to lincomycin by nucleotidylation, located on Tn6260 from Enterococcus faecalis E531.
    J Antimicrob Chemother. 2016 Dec 30. pii: dkw549. doi: 10.1093.
    PubMed     Text format     Abstract available


  211. VAN HAL SJ, Espedido BA, Coombs GW, Howden BP, et al
    Polyclonal emergence of vanA vancomycin-resistant Enterococcus faecium in Australia.
    J Antimicrob Chemother. 2016 Dec 28. pii: dkw539. doi: 10.1093.
    PubMed     Text format     Abstract available


  212. PENG H, Hu Q, Shang W, Yuan J, et al
    WalK(S221P), a naturally occurring mutation, confers vancomycin resistance in VISA strain XN108.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw518. doi: 10.1093.
    PubMed     Text format     Abstract available


  213. POMBA C, Rantala M, Greko C, Baptiste KE, et al
    Public health risk of antimicrobial resistance transfer from companion animals.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw481. doi: 10.1093.
    PubMed     Text format     Abstract available


  214. NAGU TJ, Aboud S, Matee MI, Maeurer MJ, et al
    Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw503. doi: 10.1093.
    PubMed     Text format     Abstract available


  215. LAHRA MM, Trembizki E, Buckley C, Donovan B, et al
    Changes in the rates of Neisseria gonorrhoeae antimicrobial resistance are primarily driven by dynamic fluctuations in common gonococcal genotypes.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw452. doi: 10.1093.
    PubMed     Text format     Abstract available


  216. ROY CHOWDHURY P, Scott MJ, Djordjevic SP
    Genomic islands 1 and 2 carry multiple antibiotic resistance genes in Pseudomonas aeruginosa ST235, ST253, ST111 and ST175 and are globally dispersed.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw471. doi: 10.1093.
    PubMed     Text format    


  217. RIGHI E, Peri AM, Harris PN, Wailan AM, et al
    Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw459. doi: 10.1093.
    PubMed     Text format     Abstract available


  218. KWONG JC, Schultz MB, Williamson DA, Stinear TP, et al
    Comment on: Benchmarking of methods for identification of antimicrobial resistance genes in bacterial whole genome data.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw473. doi: 10.1093.
    PubMed     Text format    


  219. BUTIN M, Martins-Simoes P, Pichon B, Leyssene D, et al
    Emergence and dissemination of a linezolid-resistant Staphylococcus capitis clone in Europe.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw516. doi: 10.1093.
    PubMed     Text format     Abstract available


  220. BRITT NS, Patel N, Shireman TI, El Atrouni WI, et al
    Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw453. doi: 10.1093.
    PubMed     Text format     Abstract available


  221. CAVACO LM, Bernal JF, Zankari E, Leon M, et al
    Detection of linezolid resistance due to the optrA gene in Enterococcus faecalis from poultry meat from the American continent (Colombia).
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw490. doi: 10.1093.
    PubMed     Text format     Abstract available


  222. TANIGUCHI R, Kimura K, Miyazaki A, Banno H, et al
    High rate of slowly-killed-by-ampicillin phenotype among group B streptococci with reduced penicillin susceptibility.
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw500. doi: 10.1093.
    PubMed     Text format    


    November 2016
  223. SWEENEY D, Stoneburner A, Shinabarger DL, Arhin FF, et al
    Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


    October 2016
  224. BEETON ML, Spiller OB
    Antibiotic resistance among Ureaplasma spp. isolates: cause for concern?
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  225. GOIRE N, Kundu R, Trembizki E, Buckley C, et al
    Mixed gonococcal infections in a high-risk population, Sydney, Australia 2015: implications for antimicrobial resistance surveillance?
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  226. JEAN SS, Hsueh PR
    Distribution of ESBLs, AmpC beta-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resist
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


    September 2016
  227. FALK L, Jensen JS
    Successful outcome of macrolide-resistant Mycoplasma genitalium urethritis after spectinomycin treatment: a case report.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  228. DAY M, Doumith M, Jenkins C, Dallman TJ, et al
    Antimicrobial resistance in Shiga toxin-producing Escherichia coli serogroups O157 and O26 isolated from human cases of diarrhoeal disease in England, 2015.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  229. SCHMIDT K, Mwaigwisya S, Crossman LC, Doumith M, et al
    Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencing.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  230. MICALLEF C, Kildonaviciute K, Castro-Sanchez E, Scibor-Stepien A, et al
    Patient and public understanding and knowledge of antimicrobial resistance and stewardship in a UK hospital: should public campaigns change focus?
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  231. MULDER M, Kiefte-de Jong JC, Goessens WH, de Visser H, et al
    Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  232. KUBICEK-SUTHERLAND JZ, Lofton H, Vestergaard M, Hjort K, et al
    Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  233. LENHARD JR, Bulitta JB, Connell TD, King-Lyons N, et al
    High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  234. ARGUDIN MA, Dodemont M, Taguemount M, Roisin S, et al
    In vitro activity of ceftaroline against clinical Staphylococcus aureus isolates collected during a national survey conducted in Belgian hospitals.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  235. ZUSMAN O, Altunin S, Koppel F, Dishon Benattar Y, et al
    Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  236. PIETSCH F, Bergman JM, Brandis G, Marcusson LL, et al
    Ciprofloxacin selects for RNA polymerase mutations with pleiotropic antibiotic resistance effects.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  237. MORICI E, Simoni S, Brenciani A, Giovanetti E, et al
    A new mosaic integrative and conjugative element from Streptococcus agalactiae carrying resistance genes for chloramphenicol (catQ) and macrolides [mef(I) and erm(TR)].
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  238. MENDES RE, Castanheira M, Farrell DJ, Flamm RK, et al
    Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potency.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  239. PINHOLT M, Gumpert H, Bayliss S, Nielsen JB, et al
    Genomic analysis of 495 vancomycin-resistant Enterococcus faecium reveals broad dissemination of a vanA plasmid in more than 19 clones from Copenhagen, Denmark.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  240. BERNARD C, Aubry A, Chauffour A, Brossier F, et al
    In vivo Mycobacterium tuberculosis fluoroquinolone resistance emergence: a complex phenomenon poorly detected by current diagnostic tests.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  241. DORADO-GARCIA A, Mevius DJ, Jacobs JJ, Van Geijlswijk IM, et al
    Quantitative assessment of antimicrobial resistance in livestock during the course of a nationwide antimicrobial use reduction in the Netherlands.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  242. FUURSTED K, Stegger M, Hoffmann S, Lambertsen L, et al
    Description and characterization of a penicillin-resistant Streptococcus dysgalactiae subsp. equisimilis clone isolated from blood in three epidemiologically linked patients.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  243. NAIR S, Ashton P, Doumith M, Connell S, et al
    WGS for surveillance of antimicrobial resistance: a pilot study to detect the prevalence and mechanism of resistance to azithromycin in a UK population of non-typhoidal Salmonella.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


    August 2016
  244. LE PAGE S, Dubourg G, Rolain JM
    Evaluation of the Scan(R) 1200 as a rapid tool for reading antibiotic susceptibility testing by the disc diffusion technique.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  245. TORUMKUNEY D, Chaiwarith R, Reechaipichitkul W, Malatham K, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2012-14 in Thailand, India, South Korea and Singapore.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  246. CARTER GP, Buultjens AH, Ballard SA, Baines SL, et al
    Emergence of endemic MLST non-typeable vancomycin-resistant Enterococcus faecium.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  247. FRAVEGA J, Alvarez R, Diaz F, Inostroza O, et al
    Salmonella Typhimurium exhibits fluoroquinolone resistance mediated by the accumulation of the antioxidant molecule H2S in a CysK-dependent manner.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  248. CHONG GM, van der Beek MT, von dem Borne PA, Boelens J, et al
    PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay(R) in 201 patients with haematological disease suspected for invasive aspergillosis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  249. HUA X, Shu J, Ruan Z, Yu Y, et al
    Multiplication of blaOXA-23 is common in clinical Acinetobacter baumannii, but does not enhance carbapenem resistance.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  250. LAHIRI SD, Alm RA
    Identification of non-PBP2a resistance mechanisms in Staphylococcus aureus after serial passage with ceftaroline: involvement of other PBPs.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  251. WARBURTON PJ, Amodeo N, Roberts AP
    Mosaic tetracycline resistance genes encoding ribosomal protection proteins.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  252. VERWEIJ PE, Lestrade PP, Melchers WJ, Meis JF, et al
    Azole resistance surveillance in Aspergillus fumigatus: beneficial or biased?
    J Antimicrob Chemother. 2016;71:2079-82.
    PubMed     Text format     Abstract available


  253. ALANIO A, Denis B, Hamane S, Raffoux E, et al
    New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?
    J Antimicrob Chemother. 2016;71:2075-8.
    PubMed     Text format     Abstract available


    July 2016
  254. MACHUCA J, Ortiz M, Recacha E, Diaz-De-Alba P, et al
    Impact of AAC(6')-Ib-cr in combination with chromosomal-mediated mechanisms on clinical quinolone resistance in Escherichia coli.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  255. TSAO S, Weber S, Cameron C, Nehme D, et al
    Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


    June 2016
  256. CLAUSEN PT, Zankari E, Aarestrup FM, Lund O, et al
    Benchmarking of methods for identification of antimicrobial resistance genes in bacterial whole genome data.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  257. CHIN TL, McNulty C, Beck C, MacGowan A, et al
    Antimicrobial resistance surveillance in urinary tract infections in primary care.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  258. SINEL C, Cosquer T, Auzou M, Goux D, et al
    Sequential steps of daptomycin resistance in Enterococcus faecium and reversion to hypersusceptibility through IS-mediated inactivation of the liaFSR operon.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  259. KIM J, Han X, Bae J, Chui L, et al
    Prevalence of plasmid-mediated quinolone resistance (PMQR) genes in non-typhoidal Salmonella strains with resistance and reduced susceptibility to fluoroquinolones from human clinical cases in Alberta, Canada, 2009-13.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  260. KARLSSON E, Golovliov I, Larkeryd A, Granberg M, et al
    Clonality of erythromycin resistance in Francisella tularensis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  261. CONCEICAO T, de Lencastre H, Aires-de-Sousa M
    Efficacy of octenidine against antibiotic-resistant Staphylococcus aureus epidemic clones.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  262. HAMPRECHT A, Rohde AM, Behnke M, Feihl S, et al
    Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  263. BAR-YOSEPH H, Hussein K, Braun E, Paul M, et al
    Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  264. PFALLER MA, Messer SA, Rhomberg PR, Jones RN, et al
    Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  265. CHUNG M, Kim CK, Conceicao T, Aires-De-Sousa M, et al
    Heterogeneous oxacillin-resistant phenotypes and production of PBP2A by oxacillin-susceptible/mecA-positive MRSA strains from Africa.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  266. EILERTSON B, Maruri F, Blackman A, Guo Y, et al
    A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  267. INZAULE SC, Weidle PJ, Yang C, Ndiege K, et al
    Prevalence and dynamics of the K65R drug resistance mutation in HIV-1-infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk.
    J Antimicrob Chemother. 2016;71:1619-26.
    PubMed     Text format     Abstract available


  268. SENNATI S, Riccobono E, Di Pilato V, Villagran AL, et al
    pHN7A8-related multiresistance plasmids (blaCTX-M-65, fosA3 and rmtB) detected in clinical isolates of Klebsiella pneumoniae from Bolivia: intercontinental plasmid dissemination?
    J Antimicrob Chemother. 2016;71:1732-4.
    PubMed     Text format    


  269. SANCHEZ EH, Mendes RE, Sader HS, Allison GM, et al
    In vivo emergence of ceftaroline resistance during therapy for MRSA vertebral osteomyelitis.
    J Antimicrob Chemother. 2016;71:1736-8.
    PubMed     Text format    


  270. SAW HT, Webber MA, Mushtaq S, Woodford N, et al
    Inactivation or inhibition of AcrAB-TolC increases resistance of carbapenemase-producing Enterobacteriaceae to carbapenems.
    J Antimicrob Chemother. 2016;71:1510-9.
    PubMed     Text format     Abstract available


  271. FERNANDEZ J, Poirel L, Rodicio MR, Nordmann P, et al
    Concomitant and multiclonal dissemination of OXA-48-producing Klebsiella pneumoniae in a Spanish hospital.
    J Antimicrob Chemother. 2016;71:1734-6.
    PubMed     Text format    


    May 2016
  272. NIGRO SJ, Hall RM
    Loss and gain of aminoglycoside resistance in global clone 2 Acinetobacter baumannii in Australia via modification of genomic resistance islands and acquisition of plasmids.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  273. VERHOEF L, Roukens M, de Greeff S, Meessen N, et al
    Carriage of antimicrobial-resistant commensal bacteria in Dutch long-term-care facilities.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  274. SEROY JT, Grim SA, Reid GE, Wellington T, et al
    Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  275. PANTEL A, Petrella S, Veziris N, Matrat S, et al
    Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  276. MONNET DL, Safrany N, Heine N, Price C, et al
    Comment on: A systematic review of the public's knowledge and beliefs about antibiotic resistance.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  277. FREIRE MP, de Oliveira Garcia D, Cury AP, Spadao F, et al
    Outbreak of IMP-producing carbapenem-resistant Enterobacter gergoviae among kidney transplant recipients.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  278. MCCULLOUGH AR, Parekh S, Rathbone J, Del Mar CB, et al
    A systematic review of the public's knowledge and beliefs about antibiotic resistance-authors' response.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  279. DOBIASOVA H, Dolejska M
    Prevalence and diversity of IncX plasmids carrying fluoroquinolone and beta-lactam resistance genes in Escherichia coli originating from diverse sources and geographical areas.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  280. LIU P, Xue H, Wu Z, Ma J, et al
    Effect of bla regulators on the susceptible phenotype and phenotypic conversion for oxacillin-susceptible mecA-positive staphylococcal isolates.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  281. MOUGARI F, Amarsy R, Veziris N, Bastian S, et al
    Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  282. VAN PH, Binh PT, Minh NH, Morrissey I, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 in Vietnam.
    J Antimicrob Chemother. 2016;71 Suppl 1:i93-i102.
    PubMed     Text format     Abstract available


  283. TORUMKUNEY D, Gur D, Soyletir G, Gurler N, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2002-09 in Turkey.
    J Antimicrob Chemother. 2016;71 Suppl 1:i85-i91.
    PubMed     Text format     Abstract available


  284. SOYLETIR G, Altinkanat G, Gur D, Altun B, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey.
    J Antimicrob Chemother. 2016;71 Suppl 1:i71-i83.
    PubMed     Text format     Abstract available


  285. FESHCHENKO Y, Dzyublik A, Pertseva T, Bratus E, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Ukraine.
    J Antimicrob Chemother. 2016;71 Suppl 1:i63-i69.
    PubMed     Text format     Abstract available


  286. JAMSHEER A, Rafay AM, Daoud Z, Morrissey I, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in the Gulf States.
    J Antimicrob Chemother. 2016;71 Suppl 1:i45-i61.
    PubMed     Text format     Abstract available


  287. HU F, Zhu D, Wang F, Morrissey I, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 and 2013-14 in China.
    J Antimicrob Chemother. 2016;71 Suppl 1:i33-i43.
    PubMed     Text format     Abstract available


  288. TORUMKUNEY D, Chaiwarith R, Reechaipichitkul W, Malatham K, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2012-14 in Thailand, India, South Korea and Singapore.
    J Antimicrob Chemother. 2016;71 Suppl 1:i3-i19.
    PubMed     Text format     Abstract available


  289. KACOU-NDOUBA A, Revathi G, Mwathi P, Seck A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2011-14 in the Democratic Republic of Congo, Ivory Coast, Republic of Senegal and Kenya.
    J Antimicrob Chemother. 2016;71 Suppl 1:i21-i31.
    PubMed     Text format     Abstract available


  290. ZAFAR A, Hasan R, Nizamuddin S, Mahmood N, et al
    Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.
    J Antimicrob Chemother. 2016;71 Suppl 1:i103-i109.
    PubMed     Text format     Abstract available


  291. ENNE VI, Johnson AP, Perry JD
    Preface.
    J Antimicrob Chemother. 2016;71 Suppl 1:i1.
    PubMed     Text format    


  292. ARIEN KK, Venkatraj M, Michiels J, Joossens J, et al
    Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398.
    J Antimicrob Chemother. 2016;71:1159-68.
    PubMed     Text format     Abstract available


  293. JOST C, Bidet P, Carrere T, Mariani-Kurkdjian P, et al
    Susceptibility of enterohaemorrhagic Escherichia coli to azithromycin in France and analysis of resistance mechanisms.
    J Antimicrob Chemother. 2016;71:1183-7.
    PubMed     Text format     Abstract available


  294. LI L, Hassan KA, Brown MH, Paulsen IT, et al
    Rapid multiplexed phenotypic screening identifies drug resistance functions for three novel efflux pumps in Acinetobacter baumannii.
    J Antimicrob Chemother. 2016;71:1223-32.
    PubMed     Text format     Abstract available


  295. BATHOORN E, Tsioutis C, da Silva Voorham JM, Scoulica EV, et al
    Emergence of pan-resistance in KPC-2 carbapenemase-producing Klebsiella pneumoniae in Crete, Greece: a close call.
    J Antimicrob Chemother. 2016;71:1207-12.
    PubMed     Text format     Abstract available


  296. ROWLEY CF, MacLeod IJ, Maruapula D, Lekoko B, et al
    Sharp increase in rates of HIV transmitted drug resistance at antenatal clinics in Botswana demonstrates the need for routine surveillance.
    J Antimicrob Chemother. 2016;71:1361-6.
    PubMed     Text format     Abstract available


  297. PHAM QD, Wilson DP, Nguyen TV, Do NT, et al
    Projecting the epidemiological effect, cost-effectiveness and transmission of HIV drug resistance in Vietnam associated with viral load monitoring strategies.
    J Antimicrob Chemother. 2016;71:1367-79.
    PubMed     Text format     Abstract available


  298. LINKEVICIUS M, Anderssen JM, Sandegren L, Andersson DI, et al
    Fitness of Escherichia coli mutants with reduced susceptibility to tigecycline.
    J Antimicrob Chemother. 2016;71:1307-13.
    PubMed     Text format     Abstract available


  299. MOHAMED AF, Kristoffersson AN, Karvanen M, Nielsen EI, et al
    Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK/PD model.
    J Antimicrob Chemother. 2016;71:1279-90.
    PubMed     Text format     Abstract available


  300. BRASSEUR A, Hites M, Roisin S, Cotton F, et al
    A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study.
    J Antimicrob Chemother. 2016;71:1386-94.
    PubMed     Text format     Abstract available


  301. DE LUCA A, Flandre P, Dunn D, Zazzi M, et al
    Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.
    J Antimicrob Chemother. 2016;71:1352-60.
    PubMed     Text format     Abstract available


  302. MURATA S, Mushino T, Hosoi H, Kuriyama K, et al
    Extracorporeal antimicrobial elimination enables antimicrobial mixing and affects resident bacteria.
    J Antimicrob Chemother. 2016;71:1430-2.
    PubMed     Text format    


    April 2016
  303. MICHOS A, Koutouzi FI, Tsakris A, Chatzichristou P, et al
    Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  304. GOMEZ-SIMMONDS A, Hu Y, Sullivan SB, Wang Z, et al
    Evidence from a New York City hospital of rising incidence of genetically diverse carbapenem-resistant Enterobacter cloacae and dominance of ST171, 2007-14.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  305. DEPLANO A, Vandendriessche S, Nonhoff C, Dodemont M, et al
    National surveillance of Staphylococcus epidermidis recovered from bloodstream infections in Belgian hospitals.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  306. HONG J, Shu X, Liu D, Zhu Y, et al
    Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  307. REULAND EA, Al Naiemi N, Kaiser AM, Heck M, et al
    Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam.
    J Antimicrob Chemother. 2016;71:1076-82.
    PubMed     Text format     Abstract available


  308. GUBAVU C, Prazuck T, Niang M, Buret J, et al
    Dolutegravir-based monotherapy or dual therapy maintains a high proportion of viral suppression even in highly experienced HIV-1-infected patients.
    J Antimicrob Chemother. 2016;71:1046-50.
    PubMed     Text format     Abstract available


  309. LAMBERT-NICLOT S, George EC, Pozniak A, White E, et al
    Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
    J Antimicrob Chemother. 2016;71:1056-62.
    PubMed     Text format     Abstract available


  310. POND MJ, Hall CL, Miari VF, Cole M, et al
    Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy.
    J Antimicrob Chemother. 2016;71:897-902.
    PubMed     Text format     Abstract available


  311. CROWTHER GS, Chilton CH, Longshaw C, Todhunter SL, et al
    Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.
    J Antimicrob Chemother. 2016;71:986-91.
    PubMed     Text format     Abstract available


  312. SKURNIK D, Roux D, Pons S, Guillard T, et al
    Extended-spectrum antibodies protective against carbapenemase-producing Enterobacteriaceae.
    J Antimicrob Chemother. 2016;71:927-35.
    PubMed     Text format     Abstract available


  313. BEN YAAKOV D, Rivkin A, Mircus G, Albert N, et al
    Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis.
    J Antimicrob Chemother. 2016;71:946-52.
    PubMed     Text format     Abstract available


  314. GUO Q, Spychala CN, McElheny CL, Doi Y, et al
    Comparative analysis of an IncR plasmid carrying armA, blaDHA-1 and qnrB4 from Klebsiella pneumoniae ST37 isolates.
    J Antimicrob Chemother. 2016;71:882-6.
    PubMed     Text format     Abstract available


  315. SUN F, Zhou D, Wang Q, Feng J, et al
    Genetic characterization of a novel blaDIM-2-carrying megaplasmid p12969-DIM from clinical Pseudomonas putida.
    J Antimicrob Chemother. 2016;71:909-12.
    PubMed     Text format     Abstract available


    March 2016
  316. MEUNIER D, Doumith M, Findlay J, Mustafa N, et al
    Carbapenem resistance mediated by blaOXA-181 in Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  317. HUNTINGTON JA, Sakoulas G, Umeh O, Cloutier DJ, et al
    Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  318. LIN YT, Tsai JC, Yamamoto T, Chen HJ, et al
    Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  319. ANASTASI E, Giguere S, Berghaus LJ, Hondalus MK, et al
    Novel transferable erm(46) determinant responsible for emerging macrolide resistance in Rhodococcus equi.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  320. LI D, Wang Y, Schwarz S, Cai J, et al
    Co-location of the oxazolidinone resistance genes optrA and cfr on a multiresistance plasmid from Staphylococcus sciuri.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  321. COUTO N, Monchique C, Belas A, Marques C, et al
    Trends and molecular mechanisms of antimicrobial resistance in clinical staphylococci isolated from companion animals over a 16 year period.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  322. HAMIDIAN M, Hall RM
    The resistance gene complement of D4, a multiply antibiotic-resistant ST25 Acinetobacter baumannii isolate, resides in two genomic islands and a plasmid.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  323. THOMPSON CN, Thieu NT, Vinh PV, Duc AN, et al
    Clinical implications of reduced susceptibility to fluoroquinolones in paediatric Shigella sonnei and Shigella flexneri infections.
    J Antimicrob Chemother. 2016;71:807-15.
    PubMed     Text format     Abstract available


  324. DI MAIO VC, Cento V, Di Paolo D, Aragri M, et al
    HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.
    J Antimicrob Chemother. 2016;71:739-50.
    PubMed     Text format     Abstract available


  325. FABREGA A, Balleste-Delpierre C, Vila J
    Differential impact of ramRA mutations on both ramA transcription and decreased antimicrobial susceptibility in Salmonella Typhimurium.
    J Antimicrob Chemother. 2016;71:617-24.
    PubMed     Text format     Abstract available


  326. CAMPOS J, Mourao J, Marcal S, Machado J, et al
    Clinical Salmonella Typhimurium ST34 with metal tolerance genes and an IncHI2 plasmid carrying oqxAB-aac(6')-Ib-cr from Europe.
    J Antimicrob Chemother. 2016;71:843-5.
    PubMed     Text format    


  327. GANTNER P, Morand-Joubert L, Sueur C, Raffi F, et al
    Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression.
    J Antimicrob Chemother. 2016;71:751-61.
    PubMed     Text format     Abstract available


  328. THAO VP, Quang VM, Day JN, Chinh NT, et al
    High prevalence of PI resistance in patients failing second-line ART in Vietnam.
    J Antimicrob Chemother. 2016;71:762-74.
    PubMed     Text format     Abstract available


  329. KOMP LINDGREN P, Higgins PG, Seifert H, Cars O, et al
    Prevalence of hypermutators among clinical Acinetobacter baumannii isolates.
    J Antimicrob Chemother. 2016;71:661-5.
    PubMed     Text format     Abstract available


  330. YOON EJ, Goussard S, Nemec A, Lambert T, et al
    Origin in Acinetobacter gyllenbergii and dissemination of aminoglycoside-modifying enzyme AAC(6')-Ih.
    J Antimicrob Chemother. 2016;71:601-6.
    PubMed     Text format     Abstract available


  331. STRUKOVA EN, Portnoy YA, Zinner SH, Firsov AA, et al
    Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration.
    J Antimicrob Chemother. 2016;71:678-84.
    PubMed     Text format     Abstract available


  332. FLOREZ-CUADRADO D, Ugarte-Ruiz M, Quesada A, Palomo G, et al
    Description of an erm(B)-carrying Campylobacter coli isolate in Europe.
    J Antimicrob Chemother. 2016;71:841-3.
    PubMed     Text format    


  333. WANG Y, Dong Y, Deng F, Liu D, et al
    Species shift and multidrug resistance of Campylobacter from chicken and swine, China, 2008-14.
    J Antimicrob Chemother. 2016;71:666-9.
    PubMed     Text format     Abstract available


  334. HALL RM, Schwarz S
    Resistance gene naming and numbering: is it a new gene or not?
    J Antimicrob Chemother. 2016;71:569-71.
    PubMed     Text format     Abstract available


    February 2016
  335. ZIMENKOV DV, Kulagina EV, Antonova OV, Zhuravlev VY, et al
    Simultaneous drug resistance detection and genotyping of Mycobacterium tuberculosis using a low-density hydrogel microarray.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  336. HE T, Shen Y, Schwarz S, Cai J, et al
    Genetic environment of the transferable oxazolidinone/phenicol resistance gene optrA in Enterococcus faecalis isolates of human and animal origin.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  337. GUY R, Geoghegan L, Heginbothom M, Howe R, et al
    Non-susceptibility of Escherichia coli, Klebsiella spp., Pseudomonas spp., Streptococcus pneumoniae and Staphylococcus aureus in the UK: temporal trends in England, Northern Ireland, Scotland and Wales.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  338. ADLER M, Anjum M, Andersson DI, Sandegren L, et al
    Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  339. LLACER DELICADO T, Torrecilla E, Holguin A
    Deep analysis of HIV-1 natural variability across HIV-1 variants at residues associated with integrase inhibitor (INI) resistance in INI-naive individuals.
    J Antimicrob Chemother. 2016;71:362-6.
    PubMed     Text format     Abstract available


  340. BUCKLEY C, Trembizki E, Donovan B, Chen M, et al
    A real-time PCR assay for direct characterization of the Neisseria gonorrhoeae GyrA 91 locus associated with ciprofloxacin susceptibility.
    J Antimicrob Chemother. 2016;71:353-6.
    PubMed     Text format     Abstract available


  341. STEININGER C, Willinger B
    Resistance patterns in clinical isolates of pathogenic Actinomyces species.
    J Antimicrob Chemother. 2016;71:422-7.
    PubMed     Text format     Abstract available


  342. ALHASHASH F, Wang X, Paszkiewicz K, Diggle M, et al
    Increase in bacteraemia cases in the East Midlands region of the UK due to MDR Escherichia coli ST73: high levels of genomic and plasmid diversity in causative isolates.
    J Antimicrob Chemother. 2016;71:339-43.
    PubMed     Text format     Abstract available


  343. NEOGI U, Haggblom A, Singh K, Rogers LC, et al
    Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries.
    J Antimicrob Chemother. 2016;71:367-71.
    PubMed     Text format     Abstract available


  344. LANDELLE C, von Dach E, Haustein T, Agostinho A, et al
    Randomized, placebo-controlled, double-blind clinical trial to evaluate the efficacy of polyhexanide for topical decolonization of MRSA carriers.
    J Antimicrob Chemother. 2016;71:531-8.
    PubMed     Text format     Abstract available


  345. RAWSON TM, Moore LS, Gilchrist MJ, Holmes AH, et al
    Antimicrobial stewardship: are we failing in cross-specialty clinical engagement?
    J Antimicrob Chemother. 2016;71:554-9.
    PubMed     Text format     Abstract available


  346. VICIANA I, Gonzalez-Domenech CM, Palacios R, Delgado M, et al
    Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain.
    J Antimicrob Chemother. 2016;71:357-61.
    PubMed     Text format     Abstract available


  347. BRENCIANI A, Morroni G, Pollini S, Tiberi E, et al
    Characterization of novel conjugative multiresistance plasmids carrying cfr from linezolid-resistant Staphylococcus epidermidis clinical isolates from Italy.
    J Antimicrob Chemother. 2016;71:307-13.
    PubMed     Text format     Abstract available


    January 2016
  348. KOLACZKOWSKA A, Kolaczkowski M
    Drug resistance mechanisms and their regulation in non-albicans Candida species.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  349. PFEIFER Y, Hunfeld KP, Borgmann S, Maneg D, et al
    Carbapenem-resistant Acinetobacter baumannii ST78 with OXA-72 carbapenemase and ESBL gene blaCTX-M-115.
    J Antimicrob Chemother. 2016.
    PubMed     Text format    


  350. VERSPORTEN A, Bielicki J, Drapier N, Sharland M, et al
    The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  351. JAYOL A, Janvier F, Guillard T, Chau F, et al
    qnrA6 genetic environment and quinolone resistance conferred on Proteus mirabilis.
    J Antimicrob Chemother. 2016.
    PubMed     Text format     Abstract available


  352. DONNELLY JP
    Editorial: Celebrating 40 years of the Journal.
    J Antimicrob Chemother. 2016;71:1-2.
    PubMed     Text format    


  353. CHEN SC, Yin YP, Dai XQ, Unemo M, et al
    First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China.
    J Antimicrob Chemother. 2016;71:92-9.
    PubMed     Text format     Abstract available


  354. PULE CM, Sampson SL, Warren RM, Black PA, et al
    Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy.
    J Antimicrob Chemother. 2016;71:17-26.
    PubMed     Text format     Abstract available


  355. BORTOLIN M, De Vecchi E, Romano CL, Toscano M, et al
    Antibiofilm agents against MDR bacterial strains: is bioactive glass BAG-S53P4 also effective?
    J Antimicrob Chemother. 2016;71:123-7.
    PubMed     Text format     Abstract available


  356. HARRISON EM, Ba X, Blane B, Ellington MJ, et al
    PBP2a substitutions linked to ceftaroline resistance in MRSA isolates from the UK.
    J Antimicrob Chemother. 2016;71:268-9.
    PubMed     Text format    


  357. SCHAUMBURG F, Peters G, Alabi A, Becker K, et al
    Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA.
    J Antimicrob Chemother. 2016;71:41-4.
    PubMed     Text format     Abstract available


  358. SAUERBREI A, Bohn-Wippert K, Kaspar M, Krumbholz A, et al
    Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2.
    J Antimicrob Chemother. 2016;71:6-16.
    PubMed     Text format     Abstract available


  359. ANTONELLI A, D'Andrea MM, Montagnani C, Bartolesi AM, et al
    Newborn bacteraemia caused by an Aeromonas caviae producing the VIM-1 and SHV-12 beta-lactamases, encoded by a transferable plasmid.
    J Antimicrob Chemother. 2016;71:272-4.
    PubMed     Text format    


  360. LAI CC, Liu WC, Fang CT, Yang JY, et al
    Transmitted drug resistance of HIV-1 strains among individuals attending voluntary counselling and testing in Taiwan.
    J Antimicrob Chemother. 2016;71:226-34.
    PubMed     Text format     Abstract available


    December 2015
  361. BRENCIANI A, Morroni G, Vincenzi C, Manso E, et al
    Detection in Italy of two clinical Enterococcus faecium isolates carrying both the oxazolidinone and phenicol resistance gene optrA and a silent multiresistance gene cfr.
    J Antimicrob Chemother. 2015.
    PubMed     Text format    


  362. FIEDLER S, Bender JK, Klare I, Halbedel S, et al
    Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M).
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  363. MINGOIA M, Morici E, Marini E, Brenciani A, et al
    Macrolide resistance gene erm(TR) and erm(TR)-carrying genetic elements in Streptococcus agalactiae: characterization of ICESagTR7, a new composite element containing IMESp2907.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  364. LOOTS DT
    New insights into the survival mechanisms of rifampicin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  365. CAFINI F, Nguyen LT, Higashide M, Roman F, et al
    Horizontal gene transmission of the cfr gene to MRSA and Enterococcus: role of Staphylococcus epidermidis as a reservoir and alternative pathway for the spread of linezolid resistance.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    November 2015
  366. BIELICKI JA, Sharland M, Johnson AP, Henderson KL, et al
    Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  367. RODRIGUEZ-MARTINEZ JM, Lopez-Cerero L, Diaz-de-Alba P, Chamizo-Lopez FJ, et al
    Assessment of a phenotypic algorithm to detect plasmid-mediated quinolone resistance in Enterobacteriaceae.
    J Antimicrob Chemother. 2015.
    PubMed     Text format    


  368. YANG CJ, Tang HJ, Chang SY, Hsieh SM, et al
    Comparison of serological responses to single-dose azithromycin (2 g) versus benzathine penicillin G in the treatment of early syphilis in HIV-infected patients in an area of low prevalence of macrolide-resistant Treponema pallidum infection.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  369. TUCHSCHERR L, Kreis CA, Hoerr V, Flint L, et al
    Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  370. KOSTYANEV T, Bonten MJ, O'Brien S, Steel H, et al
    The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    October 2015
  371. LAHIRI SD, Alm RA
    Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  372. BARBER KE, Smith JR, Raut A, Rybak MJ, et al
    Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    September 2015
  373. DOUARRE PE, Sauvage E, Poyart C, Glaser P, et al
    Host specificity in the diversity and transfer of lsa resistance genes in group B Streptococcus.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  374. NAGANT C, Deplano A, Nonhoff C, De Mendonca R, et al
    Low prevalence of mupirocin resistance in Belgian Staphylococcus aureus isolates collected during a 10 year nationwide surveillance.
    J Antimicrob Chemother. 2015.
    PubMed     Text format    


  375. TREVINO SE, Babcock HM, Henderson JP, Lane MA, et al
    Perceptions and behaviours of infectious diseases physicians when managing urinary tract infections due to MDR organisms.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    August 2015
  376. CONCEICAO T, Coelho C, de Lencastre H, Aires-de-Sousa M, et al
    Frequent occurrence of oxacillin-susceptible mecA-positive Staphylococcus aureus (OS-MRSA) strains in two African countries.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    July 2015
  377. BAX HI, de Steenwinkel JE, Ten Kate MT, van der Meijden A, et al
    Colistin as a potentiator of anti-TB drug activity against Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  378. LUPIEN A, Gingras H, Leprohon P, Ouellette M, et al
    Induced tigecycline resistance in Streptococcus pneumoniae mutants reveals mutations in ribosomal proteins and rRNA.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  379. SEKI T, Kimura K, Reid ME, Miyazaki A, et al
    High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  380. FUHREN J, Voskuil WS, Boel CH, Haas PJ, et al
    High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  381. AGUINAGALDE L, Diez-Martinez R, Yuste J, Royo I, et al
    Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  382. FRANGE P, Assoumou L, Descamps D, Cheret A, et al
    HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
    J Antimicrob Chemother. 2015;70:2084-9.
    PubMed     Text format     Abstract available


  383. XING H, Ruan Y, Hsi JH, Kan W, et al
    Reductions in virological failure and drug resistance in Chinese antiretroviral-treated patients due to lamivudine-based regimens, 2003-12.
    J Antimicrob Chemother. 2015;70:2097-103.
    PubMed     Text format     Abstract available


  384. PFENNIGWERTH N, Geis G, Gatermann SG, Kaase M, et al
    Description of IMP-31, a novel metallo-beta-lactamase found in an ST235 Pseudomonas aeruginosa strain in Western Germany.
    J Antimicrob Chemother. 2015;70:1973-80.
    PubMed     Text format     Abstract available


  385. VIDAL LL, Santos AF, Soares MA
    Worldwide distribution of the NS3 gene 80K polymorphism among circulating hepatitis C genotype 1 viruses: implication for simeprevir usage.
    J Antimicrob Chemother. 2015;70:2024-7.
    PubMed     Text format     Abstract available


  386. BERTHET N, Perichon B, Mazuet C, Chapeton-Montes D, et al
    A vanG-type locus in Clostridium argentinense.
    J Antimicrob Chemother. 2015;70:1942-5.
    PubMed     Text format     Abstract available


  387. FARRUKEE R, Leang SK, Butler J, Lee RT, et al
    Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility.
    J Antimicrob Chemother. 2015;70:2004-12.
    PubMed     Text format     Abstract available


  388. CHARPENTIER C, Lee GQ, Rodriguez C, Visseaux B, et al
    Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.
    J Antimicrob Chemother. 2015;70:2090-6.
    PubMed     Text format     Abstract available


    June 2015
  389. ZHANG S, Chen J, Cui P, Shi W, et al
    Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    May 2015
  390. GARNAUD C, Botterel F, Sertour N, Bougnoux ME, et al
    Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  391. JENSEN RH, Astvad KM, Silva LV, Sanglard D, et al
    Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  392. WANG Y, Lv Y, Cai J, Schwarz S, et al
    A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  393. MARTINEZ E, Holmes N, Jelfs P, Sintchenko V, et al
    Genome sequencing reveals novel deletions associated with secondary resistance to pyrazinamide in MDR Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  394. LY NS, Bulitta JB, Rao GG, Landersdorfer CB, et al
    Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.
    J Antimicrob Chemother. 2015;70:1434-42.
    PubMed     Text format     Abstract available


  395. ZHANG XM, Wu H, Zhang Q, Lau TC, et al
    A novel mutation, D404N, in the connection subdomain of reverse transcriptase of HIV-1 CRF08_BC subtype confers cross-resistance to NNRTIs.
    J Antimicrob Chemother. 2015;70:1381-90.
    PubMed     Text format     Abstract available


  396. ALM RA, Johnstone MR, Lahiri SD
    Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3.
    J Antimicrob Chemother. 2015;70:1420-8.
    PubMed     Text format     Abstract available


  397. DURAFFOUR S, Lorenzo MM, Zoller G, Topalis D, et al
    ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping.
    J Antimicrob Chemother. 2015;70:1367-80.
    PubMed     Text format     Abstract available


  398. TODESCO E, Rodriguez C, Morand-Joubert L, Mercier-Darty M, et al
    Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencing.
    J Antimicrob Chemother. 2015;70:1503-6.
    PubMed     Text format     Abstract available


  399. WILLMANN M, Bezdan D, Zapata L, Susak H, et al
    Analysis of a long-term outbreak of XDR Pseudomonas aeruginosa: a molecular epidemiological study.
    J Antimicrob Chemother. 2015;70:1322-30.
    PubMed     Text format     Abstract available


  400. SOMBORO AM, Tiwari D, Bester LA, Parboosing R, et al
    NOTA: a potent metallo-beta-lactamase inhibitor.
    J Antimicrob Chemother. 2015;70:1594-6.
    PubMed     Text format    


  401. FOURATI S, Charpentier C, Amiel C, Morand-Joubert L, et al
    Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.
    J Antimicrob Chemother. 2015;70:1507-12.
    PubMed     Text format     Abstract available


    April 2015
  402. GOLDEN AR, Rosenthal M, Fultz B, Nichol KA, et al
    Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  403. RANDALL CP, Gupta A, Jackson N, Busse D, et al
    Silver resistance in Gram-negative bacteria: a dissection of endogenous and exogenous mechanisms.
    J Antimicrob Chemother. 2015;70:1037-46.
    PubMed     Text format     Abstract available


  404. AL-HATMI AM, van Diepeningen AD, Curfs-Breuker I, de Hoog GS, et al
    Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.
    J Antimicrob Chemother. 2015;70:1068-71.
    PubMed     Text format     Abstract available


  405. HE T, Shen J, Schwarz S, Wu C, et al
    Characterization of a genomic island in Stenotrophomonas maltophilia that carries a novel floR gene variant.
    J Antimicrob Chemother. 2015;70:1031-6.
    PubMed     Text format     Abstract available


  406. GRUBER TM, Gottig S, Mark L, Christ S, et al
    Pathogenicity of pan-drug-resistant Serratia marcescens harbouring blaNDM-1.
    J Antimicrob Chemother. 2015;70:1026-30.
    PubMed     Text format     Abstract available


    March 2015
  407. LI X, Cai Q, Mei H, Zhou X, et al
    The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  408. GOLDEN AR, Adam HJ, Gilmour MW, Baxter MR, et al
    Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  409. BENDER J, Strommenger B, Steglich M, Zimmermann O, et al
    Linezolid resistance in clinical isolates of Staphylococcus epidermidis from German hospitals and characterization of two cfr-carrying plasmids.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    February 2015
  410. KARAVASSILIS V, Zarkotou O, Panopoulou M, Kachrimanidou M, et al
    Wide dissemination of linezolid-resistant Staphylococcus epidermidis in Greece is associated with a linezolid-dependent ST22 clone.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  411. KIMURA K, Nagano N, Arakawa Y
    Classification of group B streptococci with reduced beta-lactam susceptibility (GBS-RBS) based on the amino acid substitutions in PBPs.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


    January 2015
  412. STEINMANN J, Hamprecht A, Vehreschild MJ, Cornely OA, et al
    Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.
    J Antimicrob Chemother. 2015.
    PubMed     Text format     Abstract available


  413. RAYMOND S, Maillard A, Amiel C, Peytavin G, et al
    Virological failure of patients on maraviroc-based antiretroviral therapy.
    J Antimicrob Chemother. 2015;70:1858-64.
    PubMed     Text format     Abstract available


  414. LOUBET P, Charpentier C, Visseaux B, Borbor A, et al
    Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study.
    J Antimicrob Chemother. 2015;70:1881-4.
    PubMed     Text format     Abstract available


  415. DANION F, Belissa E, Peytavin G, Thierry E, et al
    Non-virological response to a dolutegravir-containing regimen in a patient harbouring a E157Q-mutated virus in the integrase region.
    J Antimicrob Chemother. 2015;70:1921-3.
    PubMed     Text format    


  416. ALEXIEV I, Shankar A, Wensing AM, Beshkov D, et al
    Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity.
    J Antimicrob Chemother. 2015;70:1874-80.
    PubMed     Text format     Abstract available


  417. LAHIRI SD, Walkup GK, Whiteaker JD, Palmer T, et al
    Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC.
    J Antimicrob Chemother. 2015;70:1650-8.
    PubMed     Text format     Abstract available


  418. TODESCO E, Mercier-Darty M, Jung M, Bottero J, et al
    Ultradeep sequencing in the therapeutic management of HIV-1 infection at treatment initiation.
    J Antimicrob Chemother. 2015;70:1919-20.
    PubMed     Text format    


    December 2014
  419. MCCARTHY AJ, Harrison EM, Stanczak-Mrozek K, Leggett B, et al
    Genomic insights into the rapid emergence and evolution of MDR in Staphylococcus pseudintermedius.
    J Antimicrob Chemother. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: